Population and pharmacogenetic studies on serum cholinesterase (pseudocholinesterase) on a population of central Italy (Rome)

Cermele, Giovanni   ; Santolamazza, Carlo   ; Pulvirenti, Marisa   ; Blandamura, Vincenzo   ; Sanpietri, Elena   ; Levi, Michele   ; Pacifici, Laura E.   ; Modiano, Guido

Atti della Accademia nazionale dei Lincei. Rendiconti della Classe di scienze fisiche, matematiche e naturali, Série 8, Tome 81 (1987) no. 1, pp. 77-85

Résumé

Serum cholinesterase or pseudocholinesterase (symbol: E, for Esterase), being able to hydrolyse succinyldicholine (SCC), a substance commonly used in the first stage of general anesthesia to induce muscle relaxation, is responsible for the normally short duration (3'-4') of the myorelaxation induced by SCC. The high sensitivity to SCC of subjects with on E activity displays itself as a more or less prolonged apnea following SCC administration that may cause serious clinical problems. The main cause of the low E activity of some subjects is the occurrence of a relatively common allele, the $E_{1}^{a}$, which has associated a low E activity so that the heterozygotes for $E_{1}^{a}$ and the normal allele have a moderately prolonged apnea following SCC administration and the $E_{1}^{a}$$E_{1}^{a}$ homozygotes' apnea lasts even for hours. Thus the estimate of the frequency of the $E_{1}^{a}$ allele is relevant from the clinical, besides of the anthropological, point of view. In the present paper an $E_{1}^{a}$ gene frequency estimate $= 0.011 \pm 0.004$ was arrived at by studying 403 subjects of the Rome population. This estimate was improved by pooling it with another one obtained with another random sample from the same popu- lation and became $= 0.011 \pm 0.002$. Besides and independently from these population studies, the relationship between the E activity and the duration of the SCC-induced muscle relaxation-described by Kalow and Genest long ago (1957)-was reexamined by a different approach. A highly significant negative correlation $(r = — 0.37; P 0.001)$ was found between these two variables showing that the E activity is one of the major factors upon which depends the SCC-induced myorelaxation time even in the range of the normal values of activity of this enzyme.

Bibliographie

[1] Bourne J.G., Collier H.O.J., and Somers G.F. (1952) - Succinylcholine (succinoylcholine). Muscle relaxant of short action. «Lancet», i, 1225-1228.

[2] Brown S.S., Kalow W., Pilz W., Whittaker M. and Woronickc L. (1981) - The plasma cholinesterases: a new perspective. «Adv. Clin. Chem.», 22, 1-123. New York, London, Toronto, Sydney, San Francisco: Academic Press.

[3] Cermele G. and Modiano G. (1980) - Cause genetiche e non genetiche della ipersensibilità alla succinilcolina. «Acta anaesthesiologica Italica», 31, 811-834.

[4] Evans F.T., Gray P.W.S., Lehmann H. and Silk E. (1952) - Sensitivity to succinylcholine in relation to serum-cholinesterase. Lancet i, 1229-1230.

[5] Evans R.T., Iqbal J., Dietz A.A., Lubrano T. and Rubinstein H.M. (1980) - A family segregating for $E_{1}^{j}$ and $E_{1}^{k}$ at cholinesterase locus 1. «J. Med. Genet.», 17, 464-467.

[6] Giblett E.R. (1969) - Genetic markers in human blood. Oxford, Edinburgh: Blackwell Scientific Publications.

[7] Goedde W.H. and Agarwal D.P. (1978) - Pseudocholinesterase variation. «Human Genetics. Suppl.», 1, 45-55.

[8] Harris H. (1980) - The principles of human biochemical genetics. 3rd Ed. Amsterdam: North-Holland Publishing Co.

[9] Kalow W. (1956) - Familial incidence of low pseudocholinesterase level. «Lancet», ii, 576.

[10] Kalow W. and Genest K. (1957) - A method for the detection of atypical forms of human serum cholinesterase. Determination of dibucaine numbers. «Canad. J. Biochem. Physiol.», 35, 339-346.

[11] Kalow W. and Gunn D.R. (1957) - The relation between dose of succinylcholine and duration of apnea in man. «J. Pharmacol. Exp. Ther.», 120, 203-214.

[12] Kalow W. and Gunn D.R. (1959) - Some statistical data on atypical cholinesterase of human serum. «Ann. Hum. Genet.», 23, 239-250.

[13] Lucarini N., Lupo Di Prisco C., Zamparini L. e Terrenato L. (1976) - Incidenza della pseudocolinesterasi atipica umana nella provincia di Macerata. «Atti Accad. Naz. dei Lincei», serie VIII, XL, 686-690.

[14] Modiano G., Cermele G., Santolamazza C., Biagioni S., Scarsella G., Novelletto A., Pacifici L.E. and Toschi G. - Population and pharmacogenetic studies on serum cholinesterase (E): estimates of the $E_{1}$ and $E_{2}$ allele frequencies and of the correlation between E activity and sensitivity to succinylcholine for the population of Central Italy. «Internati. J. Anthr.», in press.

[15] Piazza A., Olivetti E., Carbonara A.G., Bargagna N., Pecosi F., Benciolini P., Cortivo P., Breda F., Domenici R. and Jayakar S. (1982) - La distribuzione di alcuni polimorfismi genetici in Italia. «La ricerca in Clinica e Laboratorio», 2, Suppl.

[16] Silver A. (1974) - The biology of cholinesterase. Series of «Frontiers of Biology», Ed.s Neuberger A. and Tatum E.L. - North Holland Publishing Co. Amsterdam-Oxford. - Amer. Elsevier Publishing Co. Inc. New York.

[17] Steegmüller H. (1975) - On the geographic distribution of pseudocholinesterase variants. «Humangenetik», 26, 167-185.

[18] Tills D., Kopec A.C. and Tills R.E. (1983) - The distribution of the human blood groups and other polymorphisms. Supplement 1. Oxford, New York, Toronto: «Oxford Monographs on Medical Genetics». Oxford University Press.

[19] Whittaker M. and Britten J.J. (1985) - Plasma cholinesterase variants. Family studies of the $E_{1}^{k}$ gene. «Hum. Hered.», 18, 364-368.